Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin

NCT ID: NCT07047040

Last Updated: 2025-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE2/PHASE3

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-15

Study Completion Date

2027-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Elective total knee arthroplasty (TKA) is the gold standard for management of arthritis-associated pain and disability in osteoarthritis patients who have failed non-operative treatment modalitiesFollowing TKA, patients experience severe pain mediated by multiple pathways Painful stimuli to the body are detected by the free endings of peripheral nerves called nociceptors. Pre-emptive analgesia is analgesia given before the onset of painful stimuli to prevent central sensitization of nervous system to subsequent stimuli that could increase pain Studies have shown that pre-emptive analgesia reduce immediate postoperative pain and also prevent the development of chronic pain by decreasing altered sensory processing . Multimodal analgesia is the rational approach to pain management since no single analgesia targets all types of pain Multimodal analgesia, which is the use of at least 2 agents with differing mechanisms for pain control, has been shown to reduce hospital length of stay by 1.2 days and rehabilitation length of stay by 10 to 13 days compared with traditional postoperative analgesia. Ketorolac is a non-steroidal anti-inflammatory drug (NSAID). It is a cost-effective non selective cox inhibitor it inhibits prostaglandin biosynthesis. It is a potent analgesic with moderate anti-inflammatory.it inhibits platelet aggregation and increases bleeding time GABA analogues like Gabapentin is a structural analogue of gamma amino butyric acid, which was introduced in 1994 as an antiepileptic drug, particularly for partial seizures These drugs supress the hyper excitability of dorsal horn neurons caused due to tissue damage. They are also known to bind to the alpha 2 - delta subunit of voltage gated calcium channels and they have anxiolytic effect In this study we will assess the analgesic efficacy of pre-operative dose of combined ketorolac and Gabapentin in patients undergoing TKA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative Osteoarthritis, Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients scheduled for unilateral total knee replacement ranging from 40-80 years of age will be selected.

Patients will be randomized into two groups. Experimental group will receive single dose of gabapentin 800 mg capsule and ketorolac 30 mg Ampule. While control group will receive normal saline ampule and empty capsule one hour prior to administration of spinal anesthesia.

Pain will be assessed postoperatively by visual analogue score at,6 hours, 12 hours and 24 hours.

total dose of analgesia in first 24 hours will be recorded. Any complications will be recorded in first 24 hours post- operative period.

Follow up:

Visual Analog Scale (VAS) will be used at 6, 12, 24 hours post-surgery for assessment of Pain. Any side effects or complications will be recorded. Time Up and Go (TUG) test after 24hrs post-operative. Oxford knee score (OKS) after 4 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Experimental group will receive single dose of gabapentin 800 mg capsule and ketorolac 30 mg Ampule, one hour prior to administration of spinal anesthesia

Group Type ACTIVE_COMPARATOR

Ketorolac Tromethamine 30 MG/ML Prefilled Syringe

Intervention Type DRUG

a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

Gabapentin

Intervention Type DRUG

a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

control group

control group will receive normal saline ampule and empty capsule one hour prior to administration of spinal anesthesia

Group Type PLACEBO_COMPARATOR

Empty Medication Capsules

Intervention Type DRUG

two empty capsules of gabapentin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ketorolac Tromethamine 30 MG/ML Prefilled Syringe

a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

Intervention Type DRUG

Gabapentin

a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

Intervention Type DRUG

Empty Medication Capsules

two empty capsules of gabapentin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients Undergoing Unilateral Total Knee Replacement from 40 years old to 80 years old

Exclusion Criteria

* Rheumatoid Arthritis History of Renal impairment Patients refused to be enrolled in the study
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nour Shaaban Abdel-Aleem Mohamed

Resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hatem Mohamed Bakr, Professor

Role: STUDY_DIRECTOR

Assiut University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University, Faculty of Medicine

Asyut, Asyut Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nour Shaaban Abdel-Aleem, Resident

Role: CONTACT

+00201157257047

Mohamed Ahmed Mahran, Professor

Role: CONTACT

+00201006134669

References

Explore related publications, articles, or registry entries linked to this study.

Skinner HB. Multimodal acute pain management. Am J Orthop (Belle Mead NJ). 2004 May;33(5 Suppl):5-9.

Reference Type BACKGROUND
PMID: 15195936 (View on PubMed)

Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. doi: 10.1097/00000542-199907000-00006.

Reference Type BACKGROUND
PMID: 10422923 (View on PubMed)

Hebl JR, Dilger JA, Byer DE, Kopp SL, Stevens SR, Pagnano MW, Hanssen AD, Horlocker TT. A pre-emptive multimodal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Reg Anesth Pain Med. 2008 Nov-Dec;33(6):510-7.

Reference Type BACKGROUND
PMID: 19258965 (View on PubMed)

Lee BH, Park JO, Suk KS, Kim TH, Lee HM, Park MS, Lee SH, Park S, Lee JY, Ko SK, Moon SH. Pre-emptive and multi-modal perioperative pain management may improve quality of life in patients undergoing spinal surgery. Pain Physician. 2013 May-Jun;16(3):E217-26.

Reference Type BACKGROUND
PMID: 23703420 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

pre-operative analgesia

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute Pain and Inflammation After Surgery
NCT00774540 COMPLETED PHASE4
Analgesia in Knee Arthroscopic Surgery
NCT02818985 COMPLETED PHASE2